A mixed methods feasibility study of nicotine-assisted smoking reduction programmes delivered by community pharmacists – The RedPharm study

BMC Public Health

Research Article

Taina Taskila¹  Jean-Francois Etter²  Susan MacAskill³  Amanda Farley⁴  Sarah Tearne⁵  Paul Aveyard⁵  Rachel H. Williams⁵ 

[1] Department of Family Care & Mental Health, Faculty of Education & Health, University of Greenwich, London, UK;Faculty of Medicine, University of Geneva, Geneva, Switzerland;Institute for Social Marketing, University of Stirling, FK9 4LA, Scotland, UK;Institute of Applied Health Sciences, University of Birmingham, Edgbaston, B15 2TT, Birmingham, UK;Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Primary Care Building, Radcliffe Observatory Quarter, Woodstock Road, OX2 6GG, Oxford, UK;

关键词: Smoking Cessation;    Standard Length;    Nicotine Replacement Therapy;    Reduction Programme;    Smoking Cessation Programme;   

DOI  :  10.1186/s12889-017-4116-z

 received in 2016-09-01, accepted in 2017-02-07,  发布年份 2017

来源: Springer

【 摘 要 】

BackgroundPivotal trials have established that, among people who have no immediate intention to quit smoking, nicotine replacement therapy (NRT) helps people reduce and eventually stop smoking. The prime aim of this trial was to investigate the feasibility of implementing such a programme in community pharmacies. In addition, we investigated the effectiveness of providing behavioural support compared with self-help methods and of shorter compared with standard length reduction programmes.MethodsPharmacists were trained to deliver a smoking reduction programme and opportunistically invite people to participate in the programme. In a 2 × 2 factorial design, eligible volunteers were randomised to either receive in-person behavioural support or a self-help booklet. In both cases, participants were supported to set targets to reduce their smoking and use behavioural techniques to assist reduction. In addition, participants were randomised to cut down and stop over 4 weeks or over 16 weeks, but in either case continue NRT for up to nine months. We assessed uptake and adherence to the programme and smoking cessation four weeks and six months after a quit day and reduction in the three months following programme end and incorporated a qualitative processes assessment.ResultsOnly 68 of the planned 160 smokers could be recruited. Pharmacists were deterred by the bureaucracy of trial enrolment and that many smokers did not return for further support. Pharmacists sometimes subverted the randomisation or provided support to participants in the self-help arm. Smokers stayed in the programme for an average of 6 weeks rather than the 9 months envisaged. Rates of follow-up declined to around 20% of participants by 12 months. There was insufficient evidence to assess whether support or speed of reduction enhanced cessation or reduction but cessation and reduction were less common overall than in the pivotal trials for licensing NRT for this indication.ConclusionsThis programme of smoking reduction and the trial design to assess its effectiveness proved unpopular to potential participants and pharmacists. As a result, the trial produced no evidence on the effectiveness of behavioural support or speed or smoking reduction. A trial of this programme in this context is unfeasible.Trial registrationISRCTN 54805841. Registered 18 March 2010.

【 授权许可】

CC BY   
© The Author(s). 2017